ACC: Small but Significant Risk for Cardiomyopathy Seen With ADHD Meds
By Elana Gotkine HealthDay Reporter
THURSDAY, March 28, 2024 -- Young adults prescribed stimulant medications for attention-deficit/hyperactivity disorder (ADHD) have an increased risk for cardiomyopathy, with the risk increasing with duration of treatment, according to a study scheduled for presentation at the annual meeting of the American College of Cardiology, held from April 6 to 8 in Atlanta.
Pauline Gerard, from the University of Colorado School of Medicine in Aurora, and colleagues conducted a retrospective cohort study to examine the relationship between cardiomyopathy and duration of stimulant medication use in adults diagnosed with ADHD aged 20 to 40 years. The window of analysis was limited to 30 years after ADHD diagnosis.
A total of 12,759 pairs of patients categorized by the presence or absence of stimulant medication prescription with a decade-long record were matched. The researchers found that the prevalence of cardiomyopathy was 0.36 and 0.31 percent in the one-year stimulant and nonstimulant groups, respectively. This prevalence increased to 0.72 and 0.53 percent in the 10-year stimulant and nonstimulant groups, respectively. The one-year stimulant group had higher odds of cardiomyopathy (odds ratio, 1.17), which increased at eight years (odds ratio, 1.57), then decreased slightly at 10 years (odds ratio, 1.37).
"The longer you leave patients on these medications, the more likely they are to develop cardiomyopathy, but the risk of that is very low," Gerard said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Prenatal Opioid Exposure Not Tied to Neuropsychiatric Disorders in Offspring
THURSDAY, April 25, 2024 -- Prenatal opioid exposure seems not to be associated with a meaningful increase in the risk for neuropsychiatric disorders in offspring, according to a...
Green Space May Benefit Mental Health in Early Childhood
WEDNESDAY, April 17, 2024 -- Green space is associated with fewer internalizing symptoms in early childhood, according to a study published online April 10 in JAMA Network...
Medications Still Effective for Treating ADHD in Children
TUESDAY, April 16, 2024 -- Medication therapy remains an important treatment for children with attention-deficit/hyperactivity disorder (ADHD), according to a review published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.